Toll Free: 1-888-928-9744
Toll Free: 1-888-928-9744
Published: Dec, 2017 | Pages:
103 | Publisher: QYResearch
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)
In this report, the United States Galectin 3 market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Galectin 3 in these regions, from 2012 to 2022 (forecast).
United States Galectin 3 market competition by top manufacturers/players, with Galectin 3 sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
Angion Biomedica Corp
Bristol-Myers Squibb Company
Galectin Therapeutics Inc
GlycoMimetics Inc
iTeos Therapeutics SA
MandalMed Inc
...
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
GAL-300
GRMD-03
ANG-4021
KTI
Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Liver Cirrhosis
Portal Hypertension
Metastatic Melanoma
Others
If you have any special requirements, please let us know and we will offer you the report as you want.
Table of Contents
United States Galectin 3 Market Report 2017
1 Galectin 3 Overview
1.1 Product Overview and Scope of Galectin 3
1.2 Classification of Galectin 3 by Product Category
1.2.1 United States Galectin 3 Market Size (Sales Volume) Comparison by Type (2012-2022)
1.2.2 United States Galectin 3 Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
1.2.3 GAL-300
1.2.4 GRMD-03
1.2.5 ANG-4021
1.2.6 KTI
1.2.7 Others
1.3 United States Galectin 3 Market by Application/End Users
1.3.1 United States Galectin 3 Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
1.3.2 Liver Cirrhosis
1.3.3 Portal Hypertension
1.3.4 Metastatic Melanoma
1.3.5 Others
1.4 United States Galectin 3 Market by Region
1.4.1 United States Galectin 3 Market Size (Value) Comparison by Region (2012-2022)
1.4.2 The West Galectin 3 Status and Prospect (2012-2022)
1.4.3 Southwest Galectin 3 Status and Prospect (2012-2022)
1.4.4 The Middle Atlantic Galectin 3 Status and Prospect (2012-2022)
1.4.5 New England Galectin 3 Status and Prospect (2012-2022)
1.4.6 The South Galectin 3 Status and Prospect (2012-2022)
1.4.7 The Midwest Galectin 3 Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Galectin 3 (2012-2022)
1.5.1 United States Galectin 3 Sales and Growth Rate (2012-2022)
1.5.2 United States Galectin 3 Revenue and Growth Rate (2012-2022)
2 United States Galectin 3 Market Competition by Players/Suppliers
2.1 United States Galectin 3 Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Galectin 3 Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Galectin 3 Average Price by Players/Suppliers (2012-2017)
2.4 United States Galectin 3 Market Competitive Situation and Trends
2.4.1 United States Galectin 3 Market Concentration Rate
2.4.2 United States Galectin 3 Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Galectin 3 Manufacturing Base Distribution, Sales Area, Product Type
3 United States Galectin 3 Sales (Volume) and Revenue (Value) by Region (2012-2017)
3.1 United States Galectin 3 Sales and Market Share by Region (2012-2017)
3.2 United States Galectin 3 Revenue and Market Share by Region (2012-2017)
3.3 United States Galectin 3 Price by Region (2012-2017)
4 United States Galectin 3 Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
4.1 United States Galectin 3 Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Galectin 3 Revenue and Market Share by Type (2012-2017)
4.3 United States Galectin 3 Price by Type (2012-2017)
4.4 United States Galectin 3 Sales Growth Rate by Type (2012-2017)
5 United States Galectin 3 Sales (Volume) by Application (2012-2017)
5.1 United States Galectin 3 Sales and Market Share by Application (2012-2017)
5.2 United States Galectin 3 Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities
6 United States Galectin 3 Players/Suppliers Profiles and Sales Data
6.1 Angion Biomedica Corp
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Galectin 3 Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Angion Biomedica Corp Galectin 3 Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Bristol-Myers Squibb Company
6.2.2 Galectin 3 Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Bristol-Myers Squibb Company Galectin 3 Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Galectin Therapeutics Inc
6.3.2 Galectin 3 Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Galectin Therapeutics Inc Galectin 3 Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 GlycoMimetics Inc
6.4.2 Galectin 3 Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 GlycoMimetics Inc Galectin 3 Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 iTeos Therapeutics SA
6.5.2 Galectin 3 Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 iTeos Therapeutics SA Galectin 3 Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 MandalMed Inc
6.6.2 Galectin 3 Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 MandalMed Inc Galectin 3 Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
...
7 Galectin 3 Manufacturing Cost Analysis
7.1 Galectin 3 Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Galectin 3
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Galectin 3 Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Galectin 3 Major Manufacturers in 2016
8.4 Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 United States Galectin 3 Market Size (Value and Volume) Forecast (2017-2022)
11.1 United States Galectin 3 Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Galectin 3 Sales Volume Forecast by Type (2017-2022)
11.3 United States Galectin 3 Sales Volume Forecast by Application (2017-2022)
11.4 United States Galectin 3 Sales Volume Forecast by Region (2017-2022)
12 Research Findings and Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
List of Tables and Figures
Figure Product Picture of Galectin 3
Figure United States Galectin 3 Market Size (K Units) by Type (2012-2022)
Figure United States Galectin 3 Sales Volume Market Share by Type (Product Category) in 2016
Figure GAL-300 Product Picture
Figure GRMD-03 Product Picture
Figure ANG-4021 Product Picture
Figure KTI Product Picture
Figure Others Product Picture
Figure United States Galectin 3 Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Galectin 3 by Application in 2016
Figure Liver Cirrhosis Examples
Table Key Downstream Customer in Liver Cirrhosis
Figure Portal Hypertension Examples
Table Key Downstream Customer in Portal Hypertension
Figure Metastatic Melanoma Examples
Table Key Downstream Customer in Metastatic Melanoma
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Galectin 3 Market Size (Million USD) by Region (2012-2022)
Figure The West Galectin 3 Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Galectin 3 Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Galectin 3 Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Galectin 3 Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Galectin 3 Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Galectin 3 Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Galectin 3 Sales (K Units) and Growth Rate (2012-2022)
Figure United States Galectin 3 Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Galectin 3 Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Galectin 3 Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Galectin 3 Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Galectin 3 Sales Share by Players/Suppliers
Figure 2017 United States Galectin 3 Sales Share by Players/Suppliers
Figure United States Galectin 3 Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Galectin 3 Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Galectin 3 Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Galectin 3 Revenue Share by Players/Suppliers
Figure 2017 United States Galectin 3 Revenue Share by Players/Suppliers
Table United States Market Galectin 3 Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Galectin 3 Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Galectin 3 Market Share of Top 3 Players/Suppliers
Figure United States Galectin 3 Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Galectin 3 Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Galectin 3 Product Category
Table United States Galectin 3 Sales (K Units) by Region (2012-2017)
Table United States Galectin 3 Sales Share by Region (2012-2017)
Figure United States Galectin 3 Sales Share by Region (2012-2017)
Figure United States Galectin 3 Sales Market Share by Region in 2016
Table United States Galectin 3 Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Galectin 3 Revenue Share by Region (2012-2017)
Figure United States Galectin 3 Revenue Market Share by Region (2012-2017)
Figure United States Galectin 3 Revenue Market Share by Region in 2016
Table United States Galectin 3 Price (USD/Unit) by Region (2012-2017)
Table United States Galectin 3 Sales (K Units) by Type (2012-2017)
Table United States Galectin 3 Sales Share by Type (2012-2017)
Figure United States Galectin 3 Sales Share by Type (2012-2017)
Figure United States Galectin 3 Sales Market Share by Type in 2016
Table United States Galectin 3 Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Galectin 3 Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Galectin 3 by Type (2012-2017)
Figure Revenue Market Share of Galectin 3 by Type in 2016
Table United States Galectin 3 Price (USD/Unit) by Types (2012-2017)
Figure United States Galectin 3 Sales Growth Rate by Type (2012-2017)
Table United States Galectin 3 Sales (K Units) by Application (2012-2017)
Table United States Galectin 3 Sales Market Share by Application (2012-2017)
Figure United States Galectin 3 Sales Market Share by Application (2012-2017)
Figure United States Galectin 3 Sales Market Share by Application in 2016
Table United States Galectin 3 Sales Growth Rate by Application (2012-2017)
Figure United States Galectin 3 Sales Growth Rate by Application (2012-2017)
Table Angion Biomedica Corp Basic Information List
Table Angion Biomedica Corp Galectin 3 Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Angion Biomedica Corp Galectin 3 Sales Growth Rate (2012-2017)
Figure Angion Biomedica Corp Galectin 3 Sales Market Share in United States (2012-2017)
Figure Angion Biomedica Corp Galectin 3 Revenue Market Share in United States (2012-2017)
Table Bristol-Myers Squibb Company Basic Information List
Table Bristol-Myers Squibb Company Galectin 3 Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bristol-Myers Squibb Company Galectin 3 Sales Growth Rate (2012-2017)
Figure Bristol-Myers Squibb Company Galectin 3 Sales Market Share in United States (2012-2017)
Figure Bristol-Myers Squibb Company Galectin 3 Revenue Market Share in United States (2012-2017)
Table Galectin Therapeutics Inc Basic Information List
Table Galectin Therapeutics Inc Galectin 3 Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Galectin Therapeutics Inc Galectin 3 Sales Growth Rate (2012-2017)
Figure Galectin Therapeutics Inc Galectin 3 Sales Market Share in United States (2012-2017)
Figure Galectin Therapeutics Inc Galectin 3 Revenue Market Share in United States (2012-2017)
Table GlycoMimetics Inc Basic Information List
Table GlycoMimetics Inc Galectin 3 Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure GlycoMimetics Inc Galectin 3 Sales Growth Rate (2012-2017)
Figure GlycoMimetics Inc Galectin 3 Sales Market Share in United States (2012-2017)
Figure GlycoMimetics Inc Galectin 3 Revenue Market Share in United States (2012-2017)
Table iTeos Therapeutics SA Basic Information List
Table iTeos Therapeutics SA Galectin 3 Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure iTeos Therapeutics SA Galectin 3 Sales Growth Rate (2012-2017)
Figure iTeos Therapeutics SA Galectin 3 Sales Market Share in United States (2012-2017)
Figure iTeos Therapeutics SA Galectin 3 Revenue Market Share in United States (2012-2017)
Table MandalMed Inc Basic Information List
Table MandalMed Inc Galectin 3 Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure MandalMed Inc Galectin 3 Sales Growth Rate (2012-2017)
Figure MandalMed Inc Galectin 3 Sales Market Share in United States (2012-2017)
Figure MandalMed Inc Galectin 3 Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Galectin 3
Figure Manufacturing Process Analysis of Galectin 3
Figure Galectin 3 Industrial Chain Analysis
Table Raw Materials Sources of Galectin 3 Major Players/Suppliers in 2016
Table Major Buyers of Galectin 3
Table Distributors/Traders List
Figure United States Galectin 3 Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Galectin 3 Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Galectin 3 Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Galectin 3 Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Galectin 3 Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Galectin 3 Sales Volume (K Units) Forecast by Type in 2022
Table United States Galectin 3 Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Galectin 3 Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Galectin 3 Sales Volume (K Units) Forecast by Application in 2022
Table United States Galectin 3 Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Galectin 3 Sales Volume Share Forecast by Region (2017-2022)
Figure United States Galectin 3 Sales Volume Share Forecast by Region (2017-2022)
Figure United States Galectin 3 Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.
